Trade Mark Journal No.2026/041 9 October 2026

WO0000001926796 (1,5)

Office of origin: France

Date of International Registration:24 February 2026
Date of designation in the UK: 24 February 2026
Image for mark 1926796

International priority date claimed: 9 October 2025 (France) (5187801)
Class 1
Yeast as an active ingredient used in the manufacture of pharmaceutical preparations.
Class 5
Nutritional supplements; nutritional yeast for medical or pharmaceutical use; food supplements; nutritional supplements; yeast food supplement; microorganisms for pharmaceutical and medical use; enzymes and enzyme preparations for pharmaceutical, medical or veterinary use; bacteria and bacterial preparations for pharmaceutical or medical use; yeast for pharmaceutical and medical use; probiotic preparations or other nutrients for human consumption; probiotic composition for human consumption; cultivation of microorganisms with probiotic effect on the human organism, for medical use; yeast with a probiotic effect on the human body; active pharmaceutical ingredient, namely yeast sold as a component of pharmaceutical preparations for the treatment of human flora.

LESAFFRE ET COMPAGNIE

Representative: DAUBIN Béatrice CABINET LAVOIX, 62 Rue de Bonnel, F-69448 LYON CEDEX 03, FRANCE